Carroll B J, Curtis G C, Kokmen E
Am J Psychiatry. 1977 Jul;134(7):785-9. doi: 10.1176/ajp.134.7.785.
The authors conducted an extensive pharmacological analysis of a patient severely affected by tardive dyskinesia. No drug treatment gave lasting clinical improvement. Several agents recently recommended for this condition, dimethyl aminoethanol, clozapine, and thioridazine, failed to modify the dyskinesia. Reserpine caused a worsening of the symptoms. A paradoxical and unexpected improvement was observed with apomorphine injections and with low-dosage oral L-dopa. These two drugs may have acted by stimulating presynaptic inhibitory dopamine receptors.
作者对一名患有严重迟发性运动障碍的患者进行了广泛的药理学分析。没有药物治疗能带来持久的临床改善。最近推荐用于这种疾病的几种药物,二甲基乙醇胺、氯氮平和硫利达嗪,均未能改善运动障碍。利血平使症状恶化。注射阿扑吗啡和低剂量口服左旋多巴观察到了矛盾且意外的改善。这两种药物可能是通过刺激突触前抑制性多巴胺受体起作用的。